Inactive Instrument

Alexza Pharmaceuticals, Inc. Share Price Nasdaq

Stocks

End-of-day quote Nasdaq
- ^USD	-

28/03/16	Alexza Pharmaceuticals : Reports Fourth Quarter and Year End 2015 Financial Results	PU
15/03/16	Alexza Pharmaceuticals : to Report 2015 Year End Financial Results and Provide Company Update on Monday, March 28, 2016	PU
09/03/16	Alexza Pharmaceuticals : Receives Positive Nasdaq Listing Determination	PU
27/02/16	Alexza Pharmaceuticals : Confirms Grupo Ferrer Non-binding Letter of Intent	PU
24/02/16	Alexza Pharmaceuticals : Reacquires U.S. Commercial Rights for ADASUVE® (loxapine) inhalation powder	PU

22/12/15	Alexza Pharmaceuticals : Les valeurs à suivre sur les marchés américains
22/12/15	USA-Les valeurs à suivre à Wall Street

Manager	Title	Age	Since
Mario Rovirosa Escosura CEO	Chief Executive Officer	-	-
Stacy Palermini DFI	Director of Finance/CFO	-	31/12/2002
Wolfgang Schmidt PRN	Corporate Officer/Principal	-	30/04/2019

Director	Title	Age	Since
Jorge Ramentol Massana BRD	Director/Board Member	-	20/06/2016
Sergio Ferrer-Salat Serra di Migni BRD	Director/Board Member	-	20/06/2016
Joan Fanés Trillo BRD	Director/Board Member	-	20/06/2016

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
WUXI APPTEC CO., LTD.	+3.80%	+8.10%	+63.78%	+77.70%	69.4B
ARGENX SE	-2.38%	-1.36%	+7.97%	+72.41%	57.24B
LONZA GROUP AG	-1.52%	+2.61%	+24.34%	+99.46%	57.62B
IQVIA HOLDINGS INC.	+0.41%	-3.70%	+26.06%	+34.32%	43.65B
BEONE MEDICINES AG	+2.51%	+4.22%	+20.49%	+110.71%	44.03B
REVOLUTION MEDICINES, INC.	-11.04%	-6.63%	+199.38%	+701.67%	38.08B
CELLTRION, INC.	+7.50%	+13.58%	+29.07%	+64.46%	36.31B
GENMAB A/S	-3.51%	-11.12%	+86.18%	+73.68%	32.61B
WUXI BIOLOGICS (CAYMAN) INC.	-2.18%	+7.06%	+36.06%	-4.95%	25.47B
Average	-0.72%	+2.80%	+54.82%	+136.61%	44.93B
Weighted average by Cap.	-0.38%	+3.12%	+51.19%	+130.99%

Employees

Sector